No edit summary |
Richardpruen (talk | contribs) (→Consumer Products vs Medicinal Products: added 2 papers one ecigs vs NRT one advice on flavours aided quit attempts) |
||
| Line 125: | Line 125: | ||
='''Intending to Quit Smoking'''= | ='''Intending to Quit Smoking'''= | ||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37455014/ E-cigarette support for smoking cessation: Identifying the effectiveness of intervention components in an on-line randomized optimization experiment.] === | |||
* Kimber C, Sideropoulos V, Cox S, Frings D, Naughton F, Brown J, McRobbie H, Dawkins L. Addiction. 2023 Jul 16. doi: 10.1111/add.16294. Online ahead of print. PMID: 37455014 | |||
* Measurements: The primary outcome was 4-week self-reported complete abstinence at 12 weeks post-randomization. Primary analyses were intention-to-treat (loss to follow-up recorded as smoking). Logistic regressions modelled the three- and two-way interactions and main effects, explored in that order. | |||
* Findings: In the adjusted model the only significant interaction was a two-way interaction, advice on flavour combined with text message support, which increased the odds of abstinence (odds ratio = 1.55, 95% confidence interval = 1.13–2.14, P = 0.007, Bayes factor = 7.25). There were no main effects of the intervention components. | |||
===2023 (News): [https://pubmed.ncbi.nlm.nih.gov/37041005/ Vaping: Government announces "swap to stop" scheme to cut smoking rates.] === | ===2023 (News): [https://pubmed.ncbi.nlm.nih.gov/37041005/ Vaping: Government announces "swap to stop" scheme to cut smoking rates.] === | ||
| Line 198: | Line 204: | ||
='''Consumer Products vs Medicinal Products'''= | ='''Consumer Products vs Medicinal Products'''= | ||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37458789/ Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches.] === | |||
* Rose JE, Frisbee S, Campbell D, Salley A, Claerhout S, Davis JM. Psychopharmacology (Berl). 2023 Jul 17. doi: 10.1007/s00213-023-06401-y. Online ahead of print. PMID: 37458789 | |||
* Results: The use of nicotine in ENDS led to significant reductions in smoking (ENDS nicotine vs. placebo difference in CO change = -9.2 ppm; 90% CI (-1.5 ppm, -16.9 ppm)) and was highly correlated with reductions in self-reported cigarettes per day (r=0.6). | |||
* The effect of nicotine in nicotine patches was not statistically significant (patch nicotine vs. placebo difference in CO change = -0.1 ppm; 90% CI (-7.8 ppm, 7.6 ppm)). | |||
===2023: [https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 Electronic Cigarettes for Smoking Cessation: Cochrane Living Systematic Review]=== | ===2023: [https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 Electronic Cigarettes for Smoking Cessation: Cochrane Living Systematic Review]=== | ||
edits